These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 2334914)
21. Alterations in electrophoretic mobility, diaphorase activity, and terminal differentiation induced in murine erythroleukemia lines by differentiating agents. Gascoyne PR; Becker FF J Cell Physiol; 1990 Feb; 142(2):309-15. PubMed ID: 2303526 [TBL] [Abstract][Full Text] [Related]
22. Differentiation of murine erythroleukemic cells during exposure to microwave radiation. Brown RF; Marshall SV Radiat Res; 1986 Oct; 108(1):12-22. PubMed ID: 3464992 [TBL] [Abstract][Full Text] [Related]
23. Induction of differentiation of human promyelocytic leukemia cells (HL60) by metabolites of hexamethylene bisacetamide. Snyder SW; Egorin MJ; Geelhaar LA; Hamburger AW; Callery PS Cancer Res; 1988 Jul; 48(13):3613-6. PubMed ID: 3163938 [TBL] [Abstract][Full Text] [Related]
24. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization. Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563 [TBL] [Abstract][Full Text] [Related]
25. Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases. Watanabe T; Kondo K; Oishi M Cancer Res; 1991 Feb; 51(3):764-8. PubMed ID: 1988116 [TBL] [Abstract][Full Text] [Related]
26. Changes in E2F DNA-binding activity during induced erythroid differentiation. Richon VM; Venta-Perez G Cell Growth Differ; 1996 Jan; 7(1):31-42. PubMed ID: 8788031 [TBL] [Abstract][Full Text] [Related]
27. Modulation by cAMP of 1alpha,25-dihydroxyvitamin D3 sensitivity of murine erythroleukemia cells. Waki M; Inaba M; Hiura Y; Nagasaki T; Imanishi Y; Ishimura E; Otani S; Nishizawa Y Arch Biochem Biophys; 2001 Jul; 391(2):265-70. PubMed ID: 11437358 [TBL] [Abstract][Full Text] [Related]
28. Seric factors influence cell cycle modifications during commitment of murine erythroleukemia cells to differentiation. Mencherini F; Khochbin S; Chabanas A; Lawrence JJ Cytometry; 1992; 13(5):518-24. PubMed ID: 1633731 [TBL] [Abstract][Full Text] [Related]
29. Specific erythroid differentiation of mouse erythroleukemia cells by activins and its enhancement by retinoic acids. Uchiyama H; Asashima M Biochem Biophys Res Commun; 1992 Aug; 187(1):347-52. PubMed ID: 1520319 [TBL] [Abstract][Full Text] [Related]
30. Ureido derivatives of pyridine: a new class of inducers of murine erythroleukemia cell differentiation. Pappas IS; Niopas I; Tsiftsoglou AS Anticancer Drug Des; 1992 Apr; 7(2):153-61. PubMed ID: 1575888 [TBL] [Abstract][Full Text] [Related]
32. Activin and basic fibroblast growth factor regulate neurogenesis of murine embryonal carcinoma cells. Ameerun RF; de Winter JP; van den Eijnden-van Raaij AJ; den Hertog J; de Laat SW; Tertoolen LG Cell Growth Differ; 1996 Dec; 7(12):1679-88. PubMed ID: 8959336 [TBL] [Abstract][Full Text] [Related]
33. Activin A-induced differentiation in K562 cells is associated with a transient hypophosphorylation of RB protein and the concomitant block of cell cycle at G1 phase. Sehy DW; Shao LE; Yu AL; Tsai WM; Yu J J Cell Biochem; 1992 Nov; 50(3):255-65. PubMed ID: 1361489 [TBL] [Abstract][Full Text] [Related]
34. Idiotype mimicry by a differentiation antigen on Friend erythroleukemia cells. Ardman B; DiMambro E; Levy SB; Schwartz RS J Immunol; 1987 Sep; 139(6):2038-43. PubMed ID: 3476672 [TBL] [Abstract][Full Text] [Related]
36. Proteomic analysis of erythroid differentiation induced by hexamethylene bisacetamide in murine erythroleukemia cells. Petrak J; Myslivcova D; Man P; Cmejlova J; Cmejla R; Vyoral D Exp Hematol; 2007 Feb; 35(2):193-202. PubMed ID: 17258068 [TBL] [Abstract][Full Text] [Related]
37. Mcl-1, an early-induction molecule, modulates activin A-induced apoptosis and differentiation of CML cells. Fukuchi Y; Kizaki M; Yamato K; Kawamura C; Umezawa A; Hata Ji ; Nishihara T; Ikeda Y Oncogene; 2001 Feb; 20(6):704-13. PubMed ID: 11314004 [TBL] [Abstract][Full Text] [Related]
38. Inhibition by bryostatin 1 of the phorbol ester-induced blockage of differentiation in hexamethylene bisacetamide-treated Friend erythroleukemia cells. Dell'Aquila ML; Nguyen HT; Herald CL; Pettit GR; Blumberg PM Cancer Res; 1987 Nov; 47(22):6006-9. PubMed ID: 3478136 [TBL] [Abstract][Full Text] [Related]
39. Changes in CuZn-superoxide dismutase during induced differentiation of murine erythroleukemia cells. Paoletti F; Mocali A Cancer Res; 1988 Dec; 48(23):6674-7. PubMed ID: 3180077 [TBL] [Abstract][Full Text] [Related]
40. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60. Breitman TR; He RY Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]